Literature DB >> 1968730

Prolonged neuromuscular blockade after long-term administration of vecuronium in two critically ill patients.

V Segredo1, M A Matthay, M L Sharma, L D Gruenke, J E Caldwell, R D Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1968730     DOI： 10.1097/00000542-199003000-00030

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  15 in total

1.  Full-cost determination of different levels of care in the intensive care unit. An activity-based costing approach.

Authors:  J J Doyle; J P Casciano; S R Arikian; J Mauskopf; J E Paul
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

2.  Postal survey on the long-term use of neuromuscular block in the intensive care.

Authors:  B L Appadu; J M Greiff; J P Thompson
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

Review 3.  Neuromuscular transmission and its pharmacological blockade. Part 4: Use of relaxants in paediatric and elderly patients, in obstetrics, and in the intensive care unit.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

Review 4.  Clinical pharmacokinetics of rocuronium bromide.

Authors:  K S Khuenl-Brady; H Sparr
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

5.  Assessment of double-burst monitoring at 10 mA above threshold current.

Authors:  D G Silverman; S J Brull
Journal:  Can J Anaesth       Date:  1993-06       Impact factor: 5.063

Review 6.  Which drug--steroid or benzylisoquinolinium?

Authors:  B J Pollard
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 7.  Monitoring neuromuscular function in the intensive care unit.

Authors:  J Viby-Mogensen
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 8.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

9.  Secondary hyperparathyroidism shortens the action of vecuronium in patients with chronic renal failure.

Authors:  K Takita; Y Goda; O Kemmotsu; H Mashio; A Okuyama; Y Ito; H Sakamoto; H Kawahigashi
Journal:  Can J Anaesth       Date:  1995-05       Impact factor: 5.063

10.  Duration of action of supplemental doses of vecuronium is related to the duration after the initial dose.

Authors:  T Otagiri; M Narita; M Nishizawa; C Nishimura
Journal:  J Anesth       Date:  1992-04       Impact factor: 2.078
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.